Ikarian Capital, LLC Harpoon Therapeutics, Inc. Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.78 - $5.02 $208,276 - $587,385	-117,009 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.54 - $8.08 $20,238 - $46,193	5,717 Added 5.14%	117,009 $582,000
Q3 2021 Nov 15, 2021	SELL	$7.88 - $14.0 $18,187 - $32,312	-2,308 Reduced 2.03%	111,292 $879,000
Q2 2021 Aug 16, 2021	SELL	$13.81 - $23.25 $2.14 Million - $3.6 Million	-155,000 Reduced 57.71%	113,600 $1.58 Million
Q1 2021 May 17, 2021	BUY	$17.65 - $24.16 $4.74 Million - $6.49 Million	268,600 New	268,600 $5.62 Million

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.